Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery Devices

PUBLISHER: Industry Experts | PRODUCT CODE: 1753491

Cover Image

PUBLISHER: Industry Experts | PRODUCT CODE: 1753491

Advanced Drug Delivery Systems - A Global Market Overview

PUBLISHED:
PAGES: 251 Pages, 173 Charts
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Global Site License)
USD 7200

Add to Cart

Description

Table of Contents

Advanced Drug Delivery Systems (ADDS) Market Trends and Outlook

Advanced Drug Delivery Systems (ADDS) are specialized technologies designed to modify the release, absorption, distribution, and elimination of therapeutic agents to achieve precise, controlled, or targeted drug delivery, enhancing therapeutic outcomes while minimizing adverse effects. These systems improve drug solubility, bioavailability, and therapeutic effects while reducing side effects and dosing frequency, thus improving patient compliance and health outcomes. ADDS utilizes various carriers such as nanoparticles, monoclonal antibodies, liposomes, polymeric nanoparticles, prodrugs, and microparticles to safeguard and deliver medications to targeted areas within the body. These carriers can be combined with various delivery methods, including oral systems for ease of use, injectable or parenteral methods for rapid drug action, inhalation systems for localized respiratory therapy, and implantable devices for sustained, prolonged release.

Moreover, delivery systems such as transdermal patches, topical applications, ocular and otic delivery, bioadhesive formulations, and hybrid platforms provide customized solutions for distinct clinical requirements. These adaptive delivery systems have revolutionized treatment approaches across various therapeutic fields, including oncology, cardiology, neurology, pulmonary disorders, ophthalmology, infectious diseases, inflammatory conditions, and chronic illnesses like diabetes and gastrointestinal issues. Notably, lipid-based carriers have played an essential role in facilitating the delivery of mRNA vaccines, while gene delivery systems hold significant potential for treating genetic and rare conditions. As research progresses, ADDS continues to foster innovation, leading to more personalized, targeted, and efficient therapies that are transforming the landscape of contemporary medicine.

INFOGRAPHICS


Global Advanced Drug Delivery Systems (ADDS) market is estimated at US$277 billion in 2024 and projected to post a CAGR of 6.1% between 2024 and 2030 to reach US$394.5 billion in 2030. The Advanced Drug Delivery Systems (ADDS) market is growing significantly due to the increasing incidence of chronic diseases, technological advancements, and the rising demand for personalized medicine. ADDS enhance drug release, boost bioavailability, and facilitate targeted delivery, leading to improved therapeutic results while reducing side effects. The role of nanotechnology is crucial, as nanoparticles allow for accurate drug delivery for illnesses such as cancer and cardiovascular and neurological disorders. Biologics and gene therapies create new treatment options using viral vectors and lipid nanoparticles, particularly for genetic and chronic conditions. Implantable devices provide continuous drug release, which enhances patient adherence to long-term therapy.

Key Metrics
Historical Period:2021-2023
Base Year:2024
Forecast Period:2024-2030
Units:Value market in US$
Companies Mentioned:30+

Advanced Drug Delivery Systems (ADDS) Regional Market Analysis

North America dominates the global Advanced Drug Delivery Systems (ADDS) market, capturing 39.5% of the share in 2024. This dominance is due to the robust pharmaceutical sector, rapid approval of advanced drug delivery technologies, and substantial healthcare expenditures. The U.S. is at the forefront of this region, bolstered by advancements in injectable systems, a rising incidence of chronic diseases, and an increased inclination towards self-administration. In contrast, the Asia-Pacific region is projected to be the fastest-growing region, exhibiting a 7.6% CAGR during the period 2024-2030, propelled by enhanced investments in healthcare, a vast patient demographic, and R&D initiatives supported by the government. Countries such as China, India, and Japan are encouraging the adoption of drug delivery systems through favorable government policies and expanding clinical research capabilities. As these regions progress, the combination of technological advancements, growing demand for personalized treatment options, and better access to sophisticated therapies will influence the global landscape of the ADDS market.

Advanced Drug Delivery Systems (ADDS) Market Analysis by Vehicle/Carrier Type

The nanoparticles segment dominates the Advanced Drug Delivery Systems (ADDS) market by vehicle/carrier type, holding an estimated market share of 32% in 2024, owing to their capability to improve drug solubility, allow for targeted delivery, and reduce systemic toxicity. They are widely utilized in oncology for targeted delivery of chemotherapeutics to tumor cells and in infectious disease treatment, where precise antibiotic delivery is essential. Ongoing studies into polymeric and lipid-based nanoparticles continue to expand their therapeutic applications. In contrast, monoclonal antibodies are expected to be the fastest-growing carrier segment, with a CAGR of 8% from 2024 to 2030, driven by their ability to revolutionize treatments for cancer, autoimmune disorders, and neurological conditions through precise antigen targeting. Their capacity to deliver therapies directly to affected cells increases effectiveness while reducing side effects. The rise of bispecific and trispecific antibodies, along with progress in antibody-drug conjugates (ADCs), is broadening therapeutic options and fueling the rapid growth of this segment.

Advanced Drug Delivery Systems (ADDS) Market Analysis by Application

Oncology is the largest application segment in the Advanced Drug Delivery Systems (ADDS) market, accounting for an estimated 23.4% share in 2024, driven by the growing need for targeted, effective cancer treatments with reduced side effects. The rising global cancer burden fuels demand for technologies like nanoparticles and liposomes, which enable precise drug delivery to tumor sites, enhancing therapeutic efficacy while minimizing harm to healthy tissues. In contrast, the neurology segment is anticipated to record the fastest growth rate with a CAGR of 6.7% from 2024 to 2030, driven by increased incidence of diseases like Alzheimer's, Parkinson's, and multiple sclerosis (MS). Advances in blood-brain barrier-penetrating carriers, extended-release formulations, and gene therapies are expanding treatment possibilities, while localized delivery methods, such as convection-enhanced delivery (CED) and implantable devices, enhance therapeutic efficacy. Growing awareness, early detection, and continuous innovation in drug delivery technologies position neurology as a key area for future ADDS market growth.

Advanced Drug Delivery Systems Market Report Scope

This global report on Advanced Drug Delivery Systems (ADDS) analyzes the market based on route of administration, vehicle/carrier type, and application for the period 2021-2030 with projections from 2024 to 2030 in terms of value US$. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing.

Advanced Drug Delivery Systems (ADDS) Market by Geographic Region

  • North America (The United States, Canada, and Mexico)
  • Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe)
  • Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific)
  • Rest of World

Advanced Drug Delivery Systems (ADDS) Market by Route of Administration

  • Oral
  • Injectable/Parenteral
  • Inhalation/Pulmonary
  • Transmucosal
  • Implantable Systems
  • Others (Including Topical, Transdermal, Ocular & Otic, Targeted Delivery, Bioadhesive, and Hybrid Systems)

Advanced Drug Delivery Systems (ADDS) Market by Vehicle/Carrier Type

  • Nanoparticles
  • Monoclonal Antibodies
  • Liposomes
  • Polymeric NPs
  • Prodrugs
  • Microparticles
  • Other Vehicle/Carrier Types (Including Hydrogels, Implants, Viral Vectors, and Dendrimers)

Advanced Drug Delivery Systems (ADDS) Market by Application

  • Oncology
  • Cardiology
  • Neurology
  • Pulmonary
  • Ophthalmic
  • Infectious Diseases
  • Inflammatory Diseases and Allergies
  • Other Applications (Including Diabetes, Urology, Gastrointestinal (GI) Disorders, Dermatology, Hormone Replacement Therapy and Gynecology)

Major Market Players:

  • Abbott Laboratories, Inc.
  • Abbvie, Inc.
  • Adare Pharmaceuticals, Inc
  • Alkermes, Inc.
  • Amgen, Inc.
  • AptarGroup, Inc.
  • AstraZeneca plc
  • Baxter International Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Catalent, Inc.
  • Elixir Medical Corporation
  • Evonik Industries AG
  • F. Hoffmann-La Roche AG
  • Gerresheimer AG
  • Hisamitsu Pharmaceutical Co., Inc.
  • HNS International, Inc.
  • Insulet Corporation
  • Johnson & Johnson
  • Kindeva Drug Delivery L.P.
  • Lonza Group AG
  • Medtronic plc
  • Novartis AG
  • Novavax, Inc.
  • Pfizer, Inc.
  • Recipharm AB
  • Serina Therapeutics, Inc.
  • SHL Group
  • Stevanato Group
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Vetter Pharma International GmbH
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding AG
Show more
Product Code: MES011

TABLE OF CONTENTS

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

  • 1.1. Product Outline
    • 1.1.1. Drug Delivery
      • 1.1.1.1. Conventional Dosage Forms
        • 1.1.1.1.1. Advantages of Conventional Dosage Forms
        • 1.1.1.1.2. Disadvantages of Conventional Dosage Forms
      • 1.1.1.2. Modified Release Drug Delivery System
    • 1.1.2. Advanced Drug Delivery Systems
      • 1.1.2.1. Route of Administration
        • 1.1.2.1.1. Oral
        • 1.1.2.1.2. Injectable or Parenteral
        • 1.1.2.1.3. Inhalation/Pulmonary
        • 1.1.2.1.4. Transmucosal
        • 1.1.2.1.5. Implantable Systems
        • 1.1.2.1.6. Others
      • 1.1.2.2. Vehicle/Carrier Types
        • 1.1.2.2.1. Nanoparticles
        • 1.1.2.2.2. Monoclonal Antibodies
        • 1.1.2.2.3. Liposomes
        • 1.1.2.2.4. Polymeric Nanoparticles
        • 1.1.2.2.5. Prodrugs
        • 1.1.2.2.6. Microparticles
        • 1.1.2.2.7. Other Vehicle/Carrier Types
      • 1.1.2.3. Advanced Drug Delivery Systems Applications
        • 1.1.2.3.1. Oncology
        • 1.1.2.3.2. Cardiology
        • 1.1.2.3.3. Neurology
        • 1.1.2.3.4. Pulmonary
        • 1.1.2.3.5. Ophthalmic
        • 1.1.2.3.6. Infectious Diseases
        • 1.1.2.3.7. Inflammatory Diseases & Allergies
        • 1.1.2.3.8. Other Applications

2. KEY MARKET TRENDS

  • 2.1. Nanoparticles and mAbs Primarily Shaping Parenteral Administration of ADDS
  • 2.2. Multiple Advancements Stimulating Demand for Nanoparticle-Based ADDS
  • 2.3. Integration of Monoclonal Antibodies into ADDS Expediting Demand
  • 2.4. Injectable/Parenteral Route for Drug Delivery Outpaces Oral Administration
  • 2.5. Technological Developments in ADDS Supporting Neurological Applications

3. KEY MARKET PLAYERS

  • 3.1. Abbott Laboratories
  • 3.2. AbbVie Inc.
  • 3.3. Adare Pharmaceuticals, Inc
  • 3.4. Alkermes plc
  • 3.5. Amgen, Inc.
  • 3.6. AptarGroup, Inc.
  • 3.7. AstraZeneca plc
  • 3.8. Baxter International Inc.
  • 3.9. Bayer AG
  • 3.10. Becton, Dickinson and Company
  • 3.11. Boston Scientific Corporation
  • 3.12. Bristol-Myers Squibb Company
  • 3.13. Catalent, Inc.
  • 3.14. Elixir Medical Corporation
  • 3.15. Evonik Industries AG
  • 3.16. F. Hoffmann-La Roche AG
  • 3.17. Gerresheimer AG
  • 3.18. Hisamitsu Pharmaceutical Co., Inc.
  • 3.19. HNS International, Inc.
  • 3.20. Insulet Corporation
  • 3.21. Johnson & Johnson
  • 3.22. Kindeva Drug Delivery L.P.
  • 3.23. Lonza Group AG
  • 3.24. Medtronic plc
  • 3.25. Novartis AG
  • 3.26. Novavax, Inc.
  • 3.27. Pfizer Inc.
  • 3.28. Recipharm AB
  • 3.29. Serina Therapeutics, Inc.
  • 3.30. SHL Medical
  • 3.31. Stevanato Group
  • 3.32. Terumo Corporation
  • 3.33. Teva Pharmaceutical Industries Ltd.
  • 3.34. Vetter Pharma International GmbH
  • 3.35. West Pharmaceutical Services, Inc.
  • 3.36. Ypsomed Holding AG

4. KEY BUSINESS & PRODUCT TRENDS

  • 4.1. June 2025
    • 4.1.1. Starpharma Announces Signing of a Licensing Agreement with AstraZeneca
    • 4.1.2. Evonik Partners with ST Pharm to Extend RNA and Nucleic Acid Therapeutic Offerings
  • 4.2. April 2025
    • 4.2.1. Abbott Unveils Advanced Delivery System for Proclaim DRG neurostim
  • 4.3. March 2025
    • 4.3.1. AstraZeneca Announces Acquisition of EsoBiotec
  • 4.4. January 2025
    • 4.4.1. Spektus Pharma and Recipharm Enter into a Strategic Partnership
    • 4.4.2. Vetter Unveils Upgraded V-OVS-R syringe closure system
    • 4.4.3. Sarclisa SC formulation meets Primary End Points
    • 4.4.4. Boston Scientific Announces Acquisition of Bolt Medical, Inc.
  • 4.5. December 2024
    • 4.5.1. Halozyme Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantig(TM) Utilizing ENHANZE-R Technology
    • 4.5.2. Lonza Expands Services to Support Smart Capsules Companies Developing Orally Delivered Biologics with Smart Capsule Solutions
  • 4.6. October 2024
    • 4.6.1. BD and Ypsomed Partner to Develop Injection Solutions for High-Viscosity Biologic Drugs
    • 4.6.2. Abbvie's VYALEV(TM) Receives US FDA Approval
    • 4.6.3. Aptar Pharma acquires all Device Technology Assets of SipNose Nasal Delivery Systems
    • 4.6.4. Adare Pharma Solutions Awarded 'Drug Delivery & Device Innovation', CPHI Pharma Awards 2024
    • 4.6.5. Nipro Unveils D2FT(TM) Glass Vials Featuring Stevanato Group's EZ-fill-R Technology
    • 4.6.6. Stevanato Group Announces Capacity Expansion of Vertiva
  • 4.7. September 2024
    • 4.7.1. BD Launches Neopak(TM) XtraFlow(TM) Syringe and Expands Capacity to Support Biologics Market Growth
    • 4.7.2. Evonik Introduces Novel Drug Delivery Solution: EUDRACAP-R Colon Capsules
    • 4.7.3. Adare Pharma and Laxxon Collaborate to Develop 3D Printed Oral Dosage Forms
    • 4.7.4. Ripple Therapeutics and AbbVie Join Forces to Develop RTC-620
    • 4.7.5. Aptar Pharma Partners with PULMOTREE to Advance Kolibri(TM) Non-Propellant Inhaler Platform
  • 4.8. August 2024
    • 4.8.1. Novartis and Lindy Biosciences Collaborate to Advance Subcutaneous Drug Delivery
    • 4.8.2. Insulet's Drug Delivery System Receives FDA Clearance for Type 1 & 2 Diabetes
    • 4.8.3. Evonik Announces Collaboration with KNAUER
    • 4.8.4. Abbott and Medtronic Partner to Develop Glucose Monitoring System
  • 4.9. June 2024
    • 4.9.1. Elixir Medical's Bioadaptive Implant Receives Breakthrough Device Designation by US FDA
    • 4.9.2. SCHOTT Pharma and KORU Medical Collaborate on High-Volume Subcutaneous Drug Infusion Solution
  • 4.10. May 2024
    • 4.10.1. Adare Pharma Extends High Potency Handling Capabilities
  • 4.11. April 2024
    • 4.11.1. Abbott Receives FDA approval for the Esprit scaffold
    • 4.11.2. Bespak Completes Spin-out from Recipharm
    • 4.11.3. Baxter International's Novum IQ Large Volume Infusion Pump receives US FDA Approval
  • 4.12. March 2024
    • 4.12.1. Aptar Pharma Announces Expansion of its North America Site
    • 4.12.2. Serina Therapeutics Completes Merger with AgeX Subsidiary
  • 4.13. February 2024
    • 4.13.1. Evonik Partners with the University of Mainz for Commercialization of rPEGs
  • 4.14. January 2024
    • 4.14.1. Kindeva Announces Acquisition of Summit Biosciences
    • 4.14.2. Terumo Unveils New Innovation: AZUR HydroPack Peripheral Coil System
  • 4.15. November 2023
    • 4.15.1. Serina Announces Licensing of POZ Polymer Technology to Pfizer
  • 4.16. October 2023
    • 4.16.1. SynchroMed(TM) III Drug Delivery System Received US FDA Approval
  • 4.17. September 2023
    • 4.17.1. Evonik Expands Parenteral Drug Delivery Portfolio with PLA-PEG Copolymers & Nanosonication Service
  • 4.18. June 2023
    • 4.18.1. Bayer Joins Forces with Acuitas for LNP Delivery Systems

5. GLOBAL MARKET OVERVIEW

  • 5.1. Global Advanced Drug Delivery Systems Market Overview by Route of Administration
    • 5.1.1. ADDS Route of Administration Type Market Overview by Global Region
      • 5.1.1.1. Oral
      • 5.1.1.2. Injectable/Parenteral
      • 5.1.1.3. Inhalation/Pulmonary
      • 5.1.1.4. Transmucosal
      • 5.1.1.5. Implantable Systems
      • 5.1.1.6. Other Routes of Administration
  • 5.2. Global Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
    • 5.2.1. ADDS Vehicle/Carrier Type Market Overview by Global Region
      • 5.2.1.1. Nanoparticles
      • 5.2.1.2. Monoclonal Antibodies
      • 5.2.1.3. Liposomes
      • 5.2.1.4. Polymeric Nanoparticles
      • 5.2.1.5. Prodrugs
      • 5.2.1.6. Microparticles
      • 5.2.1.7. Other Vehicle/Carrier Types
  • 5.3. Global Advanced Drug Delivery Systems Market Overview by Application
    • 5.3.1. ADDS Applications Market Overview by Global Region
      • 5.3.1.1. Oncology
      • 5.3.1.2. Cardiology
      • 5.3.1.3. Neurology
      • 5.3.1.4. Pulmonary
      • 5.3.1.5. Ophthalmic
      • 5.3.1.6. Infectious Diseases
      • 5.3.1.7. Inflammatory Diseases & Allergies
      • 5.3.1.8. Other Applications

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

6. NORTH AMERICA

  • 6.1. North American Advanced Drug Delivery Systems Market Overview by Geographic Region
  • 6.2. North American Advanced Drug Delivery Systems Market Overview by Route of Administration
  • 6.3. North American Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
  • 6.4. North American Advanced Drug Delivery Systems Market Overview by Application
  • 6.5. Country-wise Analysis of North American Advanced Drug Delivery Systems Market
    • 6.5.1. THE UNITED STATES
      • 6.5.1.1. United States Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 6.5.1.2. United States Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 6.5.1.3. United States Advanced Drug Delivery Systems Market Overview by Application
    • 6.5.2. CANADA
      • 6.5.2.1. Canadian Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 6.5.2.2. Canadian Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 6.5.2.3. Canadian Advanced Drug Delivery Systems Market Overview by Application
    • 6.5.3. MEXICO
      • 6.5.3.1. Mexican Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 6.5.3.2. Mexican Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 6.5.3.3. Mexican Advanced Drug Delivery Systems Market Overview by Application

7. EUROPE

  • 7.1. European Advanced Drug Delivery Systems Market Overview by Geographic Region
  • 7.2. European Advanced Drug Delivery Systems Market Overview by Route of Administration
  • 7.3. European Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
  • 7.4. European Advanced Drug Delivery Systems Market Overview by Application
  • 7.5. Country-wise Analysis of European Advanced Drug Delivery Systems Market
    • 7.5.1. GERMANY
      • 7.5.1.1. German Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 7.5.1.2. German Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 7.5.1.3. German Advanced Drug Delivery Systems Market Overview by Application
    • 7.5.2. FRANCE
      • 7.5.2.1. French Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 7.5.2.2. French Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 7.5.2.3. French Advanced Drug Delivery Systems Market Overview by Application
    • 7.5.3. THE UNITED KINGDOM
      • 7.5.3.1. United Kingdom Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 7.5.3.2. United Kingdom Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 7.5.3.3. United Kingdom Advanced Drug Delivery Systems Market Overview by Application
    • 7.5.4. ITALY
      • 7.5.4.1. Italian Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 7.5.4.2. Italian Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 7.5.4.3. Italian Advanced Drug Delivery Systems Market Overview by Application
    • 7.5.5. SPAIN
      • 7.5.5.1. Spanish Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 7.5.5.2. Spanish Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 7.5.5.3. Spanish Advanced Drug Delivery Systems Market Overview by Application
    • 7.5.6. REST OF EUROPE
      • 7.5.6.1. Rest of Europe Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 7.5.6.2. Rest of Europe Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 7.5.6.3. Rest of Europe Advanced Drug Delivery Systems Market Overview by Application

8. ASIA-PACIFIC

  • 8.1. Asia-Pacific Advanced Drug Delivery Systems Market Overview by Geographic Region
  • 8.2. Asia-Pacific Advanced Drug Delivery Systems Market Overview by Route of Administration
  • 8.3. Asia-Pacific Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
  • 8.4. Asia-Pacific Advanced Drug Delivery Systems Market Overview by Application
  • 8.5. Country-wise Analysis of Asia-Pacific Advanced Drug Delivery Systems Market
    • 8.5.1. JAPAN
      • 8.5.1.1. Japanese Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 8.5.1.2. Japanese Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 8.5.1.3. Japanese Advanced Drug Delivery Systems Market Overview by Application
    • 8.5.2. CHINA
      • 8.5.2.1. Chinese Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 8.5.2.2. Chinese Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 8.5.2.3. Chinese Advanced Drug Delivery Systems Market Overview by Application
    • 8.5.3. INDIA
      • 8.5.3.1. Indian Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 8.5.3.2. Indian Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 8.5.3.3. Indian Advanced Drug Delivery Systems Market Overview by Application
    • 8.5.4. SOUTH KOREA
      • 8.5.4.1. South Korean Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 8.5.4.2. South Korean Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 8.5.4.3. South Korean Advanced Drug Delivery Systems Market Overview by Application
    • 8.5.5. REST OF ASIA-PACIFIC
      • 8.5.5.1. Rest of Asia-Pacific Advanced Drug Delivery Systems Market Overview by Route of Administration
      • 8.5.5.2. Rest of Asia-Pacific Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
      • 8.5.5.3. Rest of Asia-Pacific Advanced Drug Delivery Systems Market Overview by Application

9. REST OF WORLD

  • 9.1. Rest of World Advanced Drug Delivery Systems Market Overview by Route of Administration
  • 9.2. Rest of World Advanced Drug Delivery Systems Market Overview by Vehicle/Carrier Type
  • 9.3. Rest of World Advanced Drug Delivery Systems Market Overview by Application

PART C: GUIDE TO THE INDUSTRY

  • 1. NORTH AMERICA
  • 2. EUROPE
  • 3. ASIA-PACIFIC
  • 4. REST OF WORLD

PART D: ANNEXURE

  • 1. RESEARCH METHODOLOGY
  • 2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE

  • Chart 1: Advanced Drug Delivery Systems (ADDS) Market (2024 & 2030) by Geographic Region
  • Chart 2: Advanced Drug Delivery Systems (ADDS) Market (2024 & 2030) by Route of Administration
  • Chart 3: Advanced Drug Delivery Systems (ADDS) Market (2024 & 2030) by Vehicle/Carrier Type
  • Chart 4: Advanced Drug Delivery Systems (ADDS) Market (2024 & 2030) by Application

GLOBAL MARKET OVERVIEW

  • Chart 5: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) in US$ Million
  • Chart 6: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 7: Glance at 2021, 2024 and 2030 Global Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 8: Global Advanced Oral Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 9: Glance at 2021, 2024 and 2030 Global Advanced Oral Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 10: Global Advanced Injectable/Parenteral Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 11: Glance at 2021, 2024 and 2030 Global Advanced Injectable/Parenteral Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 12: Global Advanced Inhalation/Pulmonary Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 13: Glance at 2021, 2024 and 2030 Global Advanced Inhalation/Pulmonary Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 14: Global Advanced Transmucosal Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 15: Glance at 2021, 2024 and 2030 Global Advanced Transmucosal Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 16: Global Advanced Implantable Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 17: Glance at 2021, 2024 and 2030 Global Advanced Implantable Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 18: Global Other Advanced Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 19: Glance at 2021, 2024 and 2030 Global Other Advanced Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 20: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 21: Glance at 2021, 2024 and 2030 Global Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 22: Global Nanoparticles Carrier Type Advanced Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 23: Glance at 2021, 2024 and 2030 Global Nanoparticles Carrier Type Advanced Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 24: Global Monoclonal Antibodies Carrier Type Advanced Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 25: Glance at 2021, 2024 and 2030 Global Monoclonal Antibodies Carrier Type Advanced Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 26: Global Liposomes Carrier Type Advanced Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 27: Glance at 2021, 2024 and 2030 Global Liposomes Carrier Type Advanced Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 28: Global Polymeric Nanoparticles Carrier Type Advanced Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 29: Glance at 2021, 2024 and 2030 Global Polymeric Nanoparticles Carrier Type Advanced Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 30: Global Prodrugs Carrier Type Advanced Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 31: Glance at 2021, 2024 and 2030 Global Prodrugs Carrier Type Advanced Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 32: Global Microparticles Carrier Type Advanced Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 33: Glance at 2021, 2024 and 2030 Global Microparticles Carrier Type Advanced Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 34: Global Other Vehicle/Carrier Type Advanced Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 35: Glance at 2021, 2024 and 2030 Global Other Vehicle/Carrier Type Advanced Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 36: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 37: Glance at 2021, 2024 and 2030 Global Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications
  • Chart 38: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) in Oncology Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 39: Glance at 2021, 2024 and 2030 Global Advanced Drug Delivery Systems Market Share (%) in Oncology Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 40: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) in Cardiology Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 41: Glance at 2021, 2024 and 2030 Global Advanced Drug Delivery Systems Market Share (%) in Cardiology Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 42: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) in Neurology Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 43: Glance at 2021, 2024 and 2030 Global Advanced Drug Delivery Systems Market Share (%) in Neurology Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 44: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) in Pulmonary Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 45: Glance at 2021, 2024 and 2030 Global Advanced Drug Delivery Systems Market Share (%) in Pulmonary Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 46: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) in Ophthalmic Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 47: Glance at 2021, 2024 and 2030 Global Advanced Drug Delivery Systems Market Share (%) in Ophthalmic Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 48: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) in Infectious Diseases Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 49: Glance at 2021, 2024 and 2030 Global Advanced Drug Delivery Systems Market Share (%) in Infectious Diseases Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 50: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) in Inflammatory Diseases & Allergies Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 51: Glance at 2021, 2024 and 2030 Global Advanced Drug Delivery Systems Market Share (%) in Inflammatory Diseases & Allergies Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 52: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) by in Other Applications Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 53: Glance at 2021, 2024 and 2030 Global Advanced Drug Delivery Systems Market Share in Other Applications (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE

  • Chart 54: Global Advanced Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 55: Glance at 2021, 2024 and 2030 Global Advanced Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET OVERVIEW

6. NORTH AMERICA

  • Chart 56: North American Advanced Drug Delivery Systems Market Analysis (2021-2030) in US$ Million
  • Chart 57: North American Advanced Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 58: Glance at 2021, 2024 and 2030 North American Advanced Drug Delivery Systems Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 59: North American Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 60: Glance at 2021, 2024 and 2030 North American Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 61: North American Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 62: Glance at 2021, 2024 and 2030 North American Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 63: North American Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 64: Glance at 2021, 2024 and 2030 North American Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

THE UNITED STATES

  • Chart 65: United States Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 66: Glance at 2021, 2024 and 2030 United States Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 67: United States Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 68: Glance at 2021, 2024 and 2030 United States Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 69: United States Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 70: Glance at 2021, 2024 and 2030 United States Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

CANADA

  • Chart 71: Canadian Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 72: Glance at 2021, 2024 and 2030 Canadian Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 73: Canadian Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 74: Glance at 2021, 2024 and 2030 Canadian Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 75: Canadian Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 76: Glance at 2021, 2024 and 2030 Canadian Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

MEXICO

  • Chart 77: Mexican Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 78: Glance at 2021, 2024 and 2030 Mexican Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 79: Mexican Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 80: Glance at 2021, 2024 and 2030 Mexican Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 81: Mexican Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 82: Glance at 2021, 2024 and 2030 Mexican Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

EUROPE

  • Chart 83: European Advanced Drug Delivery Systems Market Analysis (2021-2030) in US$ Million
  • Chart 84: European Advanced Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in US$ Million
  • Chart 85: Glance at 2021, 2024 and 2030 European Advanced Drug Delivery Systems Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
  • Chart 86: European Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 87: Glance at 2021, 2024 and 2030 European Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 88: European Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 89: Glance at 2021, 2024 and 2030 European Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 90: European Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 91: Glance at 2021, 2024 and 2030 European Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

GERMANY

  • Chart 92: German Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 93: Glance at 2021, 2024 and 2030 German Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 94: German Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 95: Glance at 2021, 2024 and 2030 German Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 96: German Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 97: Glance at 2021, 2024 and 2030 German Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

FRANCE

  • Chart 98: French Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 99: Glance at 2021, 2024 and 2030 French Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 100: French Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 101: Glance at 2021, 2024 and 2030 French Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 102: French Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 103: Glance at 2021, 2024 and 2030 French Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

THE UNITED KINGDOM

  • Chart 104: United Kingdom Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 105: Glance at 2021, 2024 and 2030 United Kingdom Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 106: United Kingdom Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 107: Glance at 2021, 2024 and 2030 United Kingdom Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 108: United Kingdom Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 109: Glance at 2021, 2024 and 2030 United Kingdom Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

ITALY

  • Chart 110: Italian Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 111: Glance at 2021, 2024 and 2030 Italian Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 112: Italian Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 113: Glance at 2021, 2024 and 2030 Italian Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 114: Italian Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 115: Glance at 2021, 2024 and 2030 Italian Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

SPAIN

  • Chart 116: Spanish Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 117: Glance at 2021, 2024 and 2030 Spanish Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 118: Spanish Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 119: Glance at 2021, 2024 and 2030 Spanish Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 120: Spanish Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 121: Glance at 2021, 2024 and 2030 Spanish Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

REST OF EUROPE

  • Chart 122: Rest of Europe Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 123: Glance at 2021, 2024 and 2030 Rest of Europe Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 124: Rest of Europe Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 125: Glance at 2021, 2024 and 2030 Rest of Europe Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 126: Rest of Europe Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 127: Glance at 2021, 2024 and 2030 Rest of Europe Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

ASIA-PACIFIC

  • Chart 128: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2021-2030) in US$ Million
  • Chart 129: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2021-2030) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million
  • Chart 130: Glance at 2021, 2024 and 2030 Asia-Pacific Advanced Drug Delivery Systems Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
  • Chart 131: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 132: Glance at 2021, 2024 and 2030 Asia-Pacific Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 133: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 134: Glance at 2021, 2024 and 2030 Asia-Pacific Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 135: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 136: Glance at 2021, 2024 and 2030 Asia-Pacific Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

JAPAN

  • Chart 137: Japanese Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 138: Glance at 2021, 2024 and 2030 Japanese Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 139: Japanese Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 140: Glance at 2021, 2024 and 2030 Japanese Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 141: Japanese Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 142: Glance at 2021, 2024 and 2030 Japanese Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

CHINA

  • Chart 143: Chinese Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 144: Glance at 2021, 2024 and 2030 Chinese Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 145: Chinese Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 146: Glance at 2021, 2024 and 2030 Chinese Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 147: Chinese Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 148: Glance at 2021, 2024 and 2030 Chinese Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

INDIA

  • Chart 149: Indian Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 150: Glance at 2021, 2024 and 2030 Indian Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 151: Indian Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 152: Glance at 2021, 2024 and 2030 Indian Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 153: Indian Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 154: Glance at 2021, 2024 and 2030 Indian Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

SOUTH KOREA

  • Chart 155: South Korean Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 156: Glance at 2021, 2024 and 2030 South Korean Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 157: South Korean Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 158: Glance at 2021, 2024 and 2030 South Korean Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 159: South Korean Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 160: Glance at 2021, 2024 and 2030 South Korean Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

REST OF ASIA-PACIFIC

  • Chart 161: Rest of Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 162: Glance at 2021, 2024 and 2030 Rest of Asia-Pacific Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 163: Rest of Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 164: Glance at 2021, 2024 and 2030 Rest of Asia-Pacific Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 165: Rest of Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 166: Glance at 2021, 2024 and 2030 Rest of Asia-Pacific Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications

REST OF WORLD

  • Chart 167: Rest of World Advanced Drug Delivery Systems Market Analysis (2021-2030) in US$ Million
  • Chart 168: Rest of World Advanced Drug Delivery Systems Market Analysis (2021-2030) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others in US$ Million
  • Chart 169: Glance at 2021, 2024 and 2030 Rest of World Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Injectable/Parenteral, Inhalation/Pulmonary, Transmucosal, Implantable Systems and Others
  • Chart 170: Rest of World Advanced Drug Delivery Systems Market Analysis (2021-2030) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types in US$ Million
  • Chart 171: Glance at 2021, 2024 and 2030 Rest of World Advanced Drug Delivery Systems Market Share (%) by Vehicle/Carrier Type - Nanoparticles, Monoclonal Antibodies, Liposomes, Polymeric Nanoparticles, Prodrugs, Microparticles and Other Vehicle/Carrier Types
  • Chart 172: Rest of World Advanced Drug Delivery Systems Market Analysis (2021-2030) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications in US$ Million
  • Chart 173: Glance at 2021, 2024 and 2030 Rest of World Advanced Drug Delivery Systems Market Share (%) by Application - Oncology, Cardiology, Neurology, Pulmonary, Ophthalmic, Infectious Diseases, Inflammatory Diseases & Allergies and Other Applications
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!